Open AccessClinical example of long-term control of disseminated signet-ring cell carcinoma of the stomach against the background of chemotherapy of the second line of treatment in combination with bevacizumab
Author(s) -
Т. А. Титова,
N. Besova,
Е. В. Артамонова
Publication year - 2019
Publication title -
medicinskij sovet
Language(s) - English
Resource type - Journals
eISSN - 2658-5790
pISSN - 2079-701X
DOI - 10.21518/2079-701x-2019-19-138-143
Subject(s) - docetaxel , bevacizumab , medicine , irinotecan , ramucirumab , oncology , oxaliplatin , cancer , chemotherapy , stomach cancer , paclitaxel , stomach , signet ring cell carcinoma , adenocarcinoma , colorectal cancer